CN103566077A - Medicament for treating hysteromyoma - Google Patents
Medicament for treating hysteromyoma Download PDFInfo
- Publication number
- CN103566077A CN103566077A CN201310524790.9A CN201310524790A CN103566077A CN 103566077 A CN103566077 A CN 103566077A CN 201310524790 A CN201310524790 A CN 201310524790A CN 103566077 A CN103566077 A CN 103566077A
- Authority
- CN
- China
- Prior art keywords
- medicament
- roots
- hysteromyoma
- treating hysteromyoma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 206010046798 Uterine leiomyoma Diseases 0.000 title claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 4
- 241000522649 Zornia Species 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract 2
- 235000017595 Callicarpa japonica Nutrition 0.000 abstract 1
- 240000003690 Callicarpa japonica Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 241001648640 Croton crassifolius Species 0.000 abstract 1
- 240000001360 Eragrostis japonica Species 0.000 abstract 1
- 235000010239 Grewia biloba Nutrition 0.000 abstract 1
- 241000332404 Grewia biloba Species 0.000 abstract 1
- 241001517074 Iris sanguinea Species 0.000 abstract 1
- 241000205572 Jeffersonia diphylla Species 0.000 abstract 1
- 241000717679 Mosla Species 0.000 abstract 1
- 241001078983 Tetradium ruticarpum Species 0.000 abstract 1
- 241000879313 Tiarella polyphylla Species 0.000 abstract 1
- 235000010599 Verbascum thapsus Nutrition 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 244000034971 purple passionvine Species 0.000 abstract 1
- 210000004291 uterus Anatomy 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000027758 ovulation cycle Effects 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241000416918 Polyphylla Species 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicament for treating hysteromyoma. The medicament is prepared from the following crude drugs: yanjiangqi, kwangtung beautyberry stems and leaves, croton crassifolius, Tiarella polyphylla, cavalerie mosla herbs, bloodred iris rhizoma and roots, roots of bilobed grewia, roots and leaves of narrowleaf burmann cinnamon, thin evodia roots, twinleaf zornia herbs, all-grass of Japanese lovegrass and all-grass of twocolor velvetplant. The medicament provided by the invention is reasonable in formula, exact in curative effect and capable of effectively treating hysteromyoma.
Description
Technical field
The present invention relates to oncology nursing field, specifically, relate to a kind of medicament for the treatment of hysteromyoma.
Background technology
Hysteromyoma claims again leiomyoma of uterus, is the modal a kind of benign tumors of female sex organs.How asymptomatic, minority shows as vaginal hemorrhage, and abdominal part touches swollen thing and pressure symptom etc.As can cause pain while there is torsion of pedicle or other situations, common with multiple myomata.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of hysteromyoma.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of hysteromyoma, it is made by weight by following bulk drugs:
Preferably, it is made by weight by following bulk drugs:
Preferably, described medicament of the present invention is tablet, dispersible tablet, capsule or decoction.
With reference to < < Chinese medicine voluminous dictionary > > second edition, being described as follows of the crude drug using in the present invention:
The reasonable recipe of medicament of the present invention, curative effect is clear and definite, can effectively treat hysteromyoma.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get 30 grams of 7 15 grams of rock Rhizoma Zingiberis Recens, 30 grams of Caulis Seu Folium Callicarpae Kwangtungensis, 15 grams of Radix Crotonis Crassifoliis, 10 grams of Herba tiarellae polyphyllaes, 15 grams of Herba Moslae Cavalerieis, 45 grams of Radix et Rhizoma Iridis Sanguineae, 30 grams of Radix grewiae bilobae, 10 grams of Radix seu Folium Cinnamomi angustifolii, 10 grams of trident tigers, 15 grams of Herba Zornia Diphyllae, 50 grams of Radix Pouzolziae Sanguineae and Herba Gynurae bicoloris, be placed in 5000 ml waters, at 80 ℃, reflux is 2 hours, filter, filtrate is decoction of the present invention.
Experimental example
30 routine patients are Gynecologic Outpatients, minimum 24 years old of age, maximum 48 years old.Except minority case, all there is incessant dripping of menstrual blood, companion's lumbago and lower abdomen pendant pain, menstrual cycle shortens, and menostaxis is many through blood volume; Also has hypomenorrhea, amenorrhea, fetal abortion, abortion, infertility.30 routine patients all look into uterus " B ultrasonic " prompting: body of uterus obviously increases, and sees tumor body.The course of disease is the longest 3 years, the shortest 6 months.
Choosing the decoction of preparation in embodiment 1 treats.Every day 2 times, each 50 milliliters.Within 14 days, be 1 course for the treatment of, treat six courses for the treatment of.Inactive other drug during treatment.
Treatment standard
Recovery from illness: patient's transference cure, menstrual cycle rule, few through blood volume, abdomen pendant pain, lumbago disappear, and look into: the prompting of uterus B ultrasonic: uterus size is normal range, no abnormality seen; Take a turn for the better: patient main suit's menstrual cycle rule obviously reduces through blood volume, without few abdomen pendant pain, lumbago sense, looks into: uterus B ultrasonic prompting: body of uterus obviously dwindles, tumor body scope is dwindled; Do not heal: patient's symptom has no improvement, looks into: uterus B ultrasonic prompting: unchanged without significant change, body of uterus size, tumor body has no and dwindles; According to conditions of patients, consider to adopt other method or operative treatment.
Therapeutic outcome
Described 30 routine patients are after treatment, and 18 examples meet the standard of recovery from illness, and 12 examples meet the standard of improvement.
The supervision of untoward reaction and toxic and side effects: by detect patient blood pressure, pulse, whether occur feeling sick, vomiting, dizzy clinical symptoms judge untoward reaction.Find that 30 routine patients' systolic pressure is at 90-140mmHg, diastolic pressure 60-90mmHg, pulse be 60-100 time/per minute, blood pressure and pulse all within normal range, and do not have to occur to feel sick, vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that this medicine does not have obvious toxic and side effects for human body.
Claims (3)
1. a medicament for the treatment of hysteromyoma, is characterized in that, it is to be made by weight by following bulk drugs:
2. the medicament for the treatment of hysteromyoma according to claim 1, is characterized in that, it is to be made by weight by following bulk drugs:
3. the medicament for the treatment of hysteromyoma according to claim 1 and 2, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310524790.9A CN103566077B (en) | 2013-10-31 | 2013-10-31 | A kind of medicament for the treatment of hysteromyoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310524790.9A CN103566077B (en) | 2013-10-31 | 2013-10-31 | A kind of medicament for the treatment of hysteromyoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103566077A true CN103566077A (en) | 2014-02-12 |
| CN103566077B CN103566077B (en) | 2016-02-17 |
Family
ID=50039358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310524790.9A Expired - Fee Related CN103566077B (en) | 2013-10-31 | 2013-10-31 | A kind of medicament for the treatment of hysteromyoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103566077B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1813974A (en) * | 2005-11-23 | 2006-08-09 | 王浩贵 | Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati |
-
2013
- 2013-10-31 CN CN201310524790.9A patent/CN103566077B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1813974A (en) * | 2005-11-23 | 2006-08-09 | 王浩贵 | Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103566077B (en) | 2016-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301400B (en) | A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis | |
| CN102488813B (en) | Medicine for curing fibroid | |
| CN104147194B (en) | Traditional Chinese medicine composition for treating chronic sinusitis | |
| CN103705846B (en) | The Chinese medicine preparation for the treatment of ovarian cyst | |
| CN103566077B (en) | A kind of medicament for the treatment of hysteromyoma | |
| CN103610932B (en) | Medicament for treating urinary calculus | |
| CN103705840B (en) | A kind of pharmaceutical composition and preparation method thereof for the treatment of acute and chronic cholecystitis, cholelithiasis | |
| CN102698065B (en) | Medicine composition for treating primary dysmenorrhea | |
| CN104758462B (en) | A kind of powder for the treatment of acute cholecystitis | |
| CN104547851B (en) | One treats hypertensive medicine | |
| CN104489166A (en) | Health-care tea used for anxiety | |
| CN103784765A (en) | Pharmaceutical composition for treating pains | |
| CN103585206A (en) | Preparation method of Chrysosplenium extract and its application | |
| CN102488797B (en) | Medicinal composition for treating dysmenorrhea | |
| CN103566225B (en) | Medicament for treating gynecological postoperative gastrointestinal dysfunction | |
| CN103550372B (en) | Medicament for medical abortion | |
| CN101879227B (en) | Chinese medicinal composition for treating protrusion of lumbar intervertebral disci and preparation method thereof | |
| CN102552808B (en) | Medicament for treating vaginal bleeding after abortion | |
| CN104491764A (en) | Medicine composition used for treating anus eczema | |
| CN104998036A (en) | Composition for external application treatment of hysteromyoma and ovarian cysts, and preparation method thereof | |
| CN103599503A (en) | Medicine for treating critical diseases and preparation method thereof | |
| CN104189314A (en) | Pharmaceutical composition for treating hyperlipidemia with phlegm and turbid repression syndrome | |
| CN104523798A (en) | Traditional Chinese medicine composition for treating chronic liver disease and preparation method thereof | |
| CN105147817B (en) | A kind of Chinese materia medica preparation and preparation method thereof for treating ecphyaditis | |
| CN102671048B (en) | Medicament for treating chronic urinary tract infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhiping Inventor before: Gao Dongqin |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20151106 Address after: 272100 Department of oncology, the first people's Hospital of Jining, 6 health Road, Shandong, Jining Applicant after: Zhang Zhiping Address before: 272100 people's Hospital of Jining City, Jining City, Shandong Province Health Road No. 6 Applicant before: Gao Dongqin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160217 Termination date: 20161031 |